Schedule 13G ownership disclosure
AKERO THERAPEUTICS INC
Ordinary Shares · CUSIP: 00973Y108
Event date: 2025-09-30
- Filing-level shares
- 6,280,305
- Percent of class
- 7.9%
- JANUS HENDERSON GROUP PLC
Shares: 6,280,305 · Class: 7.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000298
- Form type
- SCHEDULE 13G/A
- Filer
- Akero Therapeutics, Inc.
- CIK
- CIK 1744659
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership